The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Navigate BioPharma
Leadership - Novartis
Stock and Other Ownership Interests - Biogen; Novartis
Patents, Royalties, Other Intellectual Property - Novartis
Predictive value of circulating B cells and T cell subsets in melanoma patients treated with neoadjuvant ipilimumab and interferon.
 
Arjun Khunger
No Relationships to Disclose
 
Ghanashyam Sarikonda
Employment - Navigate BioPharma
Stock and Other Ownership Interests - Novartis
 
Jenn Tsau
Employment - Navigate BioPharma
Stock and Other Ownership Interests - Novartis
 
Zeni Alfonso
Employment - Navigate BioPharma
Stock and Other Ownership Interests - Novartis
 
Jane Gao
Employment - Navigate BioPharma
Stock and Other Ownership Interests - Novartis
 
Anil Pahuja
Employment - Navigate BioPharma
Stock and Other Ownership Interests - Novartis
 
Christian Laing
Employment - Navigate BioPharma
Stock and Other Ownership Interests - Novartis
 
Ju Young Kim
Employment - Navigate BioPharma
Stock and Other Ownership Interests - Novartis
 
Jennifer Bordeaux
Employment - Navigate BioPharma
 
Christine Vaupel
Employment - Navigate BioPharma
Stock and Other Ownership Interests - Novartis
 
Naveen Dakappagari
Employment - Navigate BioPharma
Stock and Other Ownership Interests - Biogen; Novartis
 
Shabnam Tangri
No Relationships to Disclose
 
Ahmad A. Tarhini
Consulting or Advisory Role - Array BioPharma; BioNTech; Bristol-Myers Squibb; Genentech/Roche; HUYA Bioscience International; Immunocore; Incyte; Merck; Newlink Genetics; Novartis; OncoSec; Pfizer/EMD Serono; Sanofi/Regeneron
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); GreenPeptide (Inst); Incyte (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); Prometheus (Inst); Prometheus (Inst)